Annual Total Liabilities
$39.20 M
-$339.30 K-0.86%
December 31, 2023
Summary
- As of February 7, 2025, CTCX annual total liabilities is $39.20 million, with the most recent change of -$339.30 thousand (-0.86%) on December 31, 2023.
- During the last 3 years, CTCX annual total liabilities has risen by +$8.07 million (+25.91%).
- CTCX annual total liabilities is now -0.86% below its all-time high of $39.54 million, reached on December 31, 2022.
Performance
CTCX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$6.51 M
+$100.80 K+1.57%
September 30, 2024
Summary
- As of February 7, 2025, CTCX quarterly total liabilities is $6.51 million, with the most recent change of +$100.80 thousand (+1.57%) on September 30, 2024.
- Over the past year, CTCX quarterly total liabilities has dropped by -$54.80 million (-89.39%).
- CTCX quarterly total liabilities is now -89.39% below its all-time high of $61.31 million, reached on September 30, 2023.
Performance
CTCX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CTCX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | -89.4% |
| 3 y3 years | +25.9% | -83.5% |
| 5 y5 years | +25.9% | -83.5% |
CTCX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.9% | +25.9% | -89.4% | +58.3% |
| 5 y | 5-year | -0.9% | +25.9% | -89.4% | +58.3% |
| alltime | all time | -0.9% | +25.9% | -89.4% | +58.3% |
Carmell Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.51 M(+1.6%) |
| Jun 2024 | - | $6.41 M(-15.4%) |
| Mar 2024 | - | $7.57 M(-80.7%) |
| Dec 2023 | $39.20 M | $39.20 M(-36.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $61.31 M(+1391.6%) |
| Jun 2023 | - | $4.11 M(-89.6%) |
| Dec 2022 | $39.54 M(+27.0%) | $39.54 M |
| Dec 2021 | $31.13 M | - |
FAQ
- What is Carmell Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Carmell Therapeutics?
- What is Carmell Therapeutics annual total liabilities year-on-year change?
- What is Carmell Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly total liabilities year-on-year change?
What is Carmell Therapeutics annual total liabilities?
The current annual total liabilities of CTCX is $39.20 M
What is the all time high annual total liabilities for Carmell Therapeutics?
Carmell Therapeutics all-time high annual total liabilities is $39.54 M
What is Carmell Therapeutics annual total liabilities year-on-year change?
Over the past year, CTCX annual total liabilities has changed by -$339.30 K (-0.86%)
What is Carmell Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CTCX is $6.51 M
What is the all time high quarterly total liabilities for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly total liabilities is $61.31 M
What is Carmell Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CTCX quarterly total liabilities has changed by -$54.80 M (-89.39%)